XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Reimbursement of R and D Costs (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Research and Development Reimbursement    
Total reduction to R and D expense $ 1,536 $ 1,426
Janssen    
Research and Development Reimbursement    
Total reduction to R and D expense   1,332
Viatris    
Research and Development Reimbursement    
Total reduction to R and D expense $ 1,536 $ 94